Skip to content
The Nexus
DossierENTITY

MASH

Coverage of MASH in the Nexus archive.

Earliest in view: May 27 · 12:49 UTCMost recent: Jul 11 · 13:22 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 11 · 13:22 UTCSCIENCE DAILY
    Experimental drug reverses severe fatty liver disease by repairing the gut

    An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could lead to new treatments for MASH and other gut-related diseases.

  • HEALTHMay 27 · 12:49 UTCSCIENCE DAILY
    New drug could finally stop deadly fatty liver disease

    Scientists at UC San Diego have developed ION224, an experimental drug targeting a liver enzyme to treat MASH, a severe fatty liver disease. Clinical trials showed significant improvements in liver health without requiring weight loss.

MASH · Dossier · The Nexus